The Center for Cerebrovascular Research (CCR) is a core group of faculty and staff pursuing integrative and interdisciplinary study of cerebrovascular disease, utilizing the tools of vascular cell biology, animal models, human genetics, disease epidemiology and treatment outcomes research. Our main area of focus is vascular malformations of the brain, which are an important cause of hemorrhagic stroke, and include arteriovenous malformations (AVM), intracranial aneurysms and cavernous malformations. We also have a special interest in the inherited disease, hereditary hemorrhagic telangiectasia (HHT), which is one of the few inherited causes of brain AVM.
The UCSF home departments are Anesthesia and Perioperative Care, Neurological Surgery and Neurology, with allied and collaborating faculty in a number of neuroscience and vascular biology fields. Patients and relatives searching for information on AVM (Arteriovenous malformation) can find out more about the disease and our research by reading our information on "what is an AVM"?
The CCR is headquartered in San Francisco General Hospital's historic Building 10
To advance and translate seminal metadisciplinary neuroscience, by combining insights and information across multiple perspectives and disciplines, with the common goal of providing effective, safe, and humane treatment of cerebrovascular diseases.
To provide the opportunity for students and faculty to pursue all levels of pre-doctoral, post-doctoral, and post-graduate training and intellectual development.
The 10th Annual Aneurysm and AVM Awareness Walk
Sunday May 3rd 2015, Crissy Field, San Francisco
Join us for the Anniversary celebration at the 10th Annual Aneurysm and AVM Awareness Walk
The Young-CCR Team
The Aneurysm and AVM Foundation website
The 17th National Patient and Family Conference in Santa Clara, CA
July 18th-20th 2014
The HHT Foundation Conference was a great success thanks to all of the speakers and attendees, the Center for Cerebrovascular Research (CCR) was well represented and presentations by Drs. Hua Su, Ludmila Pawlikowska and Helen Kim. Two big announcements were made at the meeting:
(1) The HHT Foundation's name will change to Cure HHT Cure HHT
(2) University of California, San Francisco (UCSF has been officially designated as an
HHT Center of Excellence
. UCSF is the only location in Northern California that specializes in the diagnosis and treatment of this disorder.
Brain Vascular Malformation Consortium (BVMC) Executive Committee Meeting
July 21th 2014, Santa Clara, CA
The BVMC, an NIH-funded research program coordinated at UCSF to study rare vascular diseases of the brain, held their annual Executive Committee meeting following the HHT Patient and Family Conference. This multicenter consortium includes three projects conducting research on cerebral cavernous malformations (CCM), Sturge-Weber syndrome (SWS), and hereditary hemorrhagic telangiectasia (HHT). CCR members who are heavily involved in the project (pictured below) include Drs. Michael T. Lawton, Helen Kim, Ludmila Pawlikowska and Charles E. McCulloch. Also attending were BVMC leaders from Duke University, University of New Mexico, Johns Hopkins University, representatives from NIH and patient advocay groups (Sturge-Weber Foundation and Cure HHT).
CCR Research Seminar
Presented by Center for Cerebrovascular Research Dept. of Anesthesia and Perioperative Care University of California, San Francisco at San Francisco General Hospital.
March 11, 2015
1:15 pm -2:00 pm
JOANNE CHAN, PhD
Department of Biological Sciences
W. Frank Fountain Research Center
Hampton University, Virginia
“Molecular Drivers of Vascular Anomaly Indicate Therapeutic Use for mTOR Inhibitory Drugs”
Medical Sciences Bldg, 513 Parnassus Ave
For Information, call:(415) 206-8906
Click here for a list of past seminars
See details on the available positions
Donate to Stroke Research